As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Johnson & Johnson: Parallax Volatility Advisers L.P., Portman Square Capital LLP, Kovack Advisors Inc., Point72 Middle East FZE, CI Private Wealth LLC, DRW Securities LLC, Jane Street Group LLC, Squarepoint Ops LLC, Millennium Management LLC, Marathon Trading Investment Management LLC, Maven Securities LTD, Nomura Holdings Inc., Boothbay Fund Management LLC, Centiva Capital LP, Jefferies Financial Group Inc., Point72 Asset Management L.P., Point72 Hong Kong Ltd, Baader Bank Aktiengesellschaft, Susquehanna International Group LLP, Verition Fund Management LLC, Cetera Investment Advisers, Marshall Wace LLP, Trustcore Financial Services LLC, Clear Street Markets LLC, Twin Tree Management LP, Wells Fargo & Company MN, Barclays PLC, Capital Fund Management S.A., JPMorgan Chase & Co., QVR LLC, Bank of America Corp DE, Capstone Investment Advisors LLC, BTG Pactual Global Asset Management Ltd, Group One Trading L.P., IMC Chicago LLC, Citigroup Inc., UBS Group AG, SpiderRock Advisors LLC, Cutler Group LLC CA, SG Americas Securities LLC, Simplex Trading LLC, Gladius Capital Management LP, Mission Wealth Management LP, Bank of Montreal Can, AMJ Financial Wealth Management, Wolverine Asset Management LLC, Trium Capital LLP, Concourse Financial Group Securities Inc., AMH Equity Ltd, and Washington Capital Management Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.